Hyiodine, the original product designed to heal complicated wounds, has caused a stir among foreign doctors. The product is now being tested in several hospitals across the world. Brand new product applications are to be presented to experts at imminent global symposia.
Dolní Dobrouč -- May 7, 2008 -- Hyiodine, the original product designed to heal complicated wounds, has caused a stir among foreign doctors. The product is now being tested in several hospitals across the world. Brand new product applications are to be presented to experts at imminent global symposia.
At the May conference of the European Wound Management Association in Lisbon, doctors will be introduced to the application of Hyiodine in skin transplants and the superb results in treating extensive lacerated wounds in the hostile conditions of a military hospital in Afghanistan. The outcome of a study by St Mary’s Hospital in Connecticut, USA, will be presented to the World Union of Wound Healing Societies (WUWHS) in Toronto this June.
Hyiodine’s unique regenerative effects significantly increase the successfulness of treatment and reduce the time required for therapy. Hyiodine use currently centres on the treatment of diabetic defects, extensive operating wounds, bedsores and other types of wounds that are difficult to treat. As doctors steadily try to gauge the extent to which the product can be used, they continue to find further areas of application where Hyiodine proves its quality and significantly speeds up the healing process.
The product has patents pending in 90 countries worldwide. The producer has registered keen interest not only from physicians, but also from international pharmaceutical corporations. Distribution agreements have been signed in 17 countries across the globe.
Profile
Contipro C, a.s. is a member of Contipro Group. The holding is one of the world’s largest producers of hyaluronan (hyaluronic acid), which is also the basis of the company’s other final pharmaceutical products. Besides wound management, the holding’s research and development operations also focus on tissue engineering, gene therapy and targeted drug delivery.
Further information:
Zuzana Bubnová, Sales Director, Contipro Group, +420 465 520 035, sales@contipro.cz , www.contipro.cz
Worlds experts set their sights on unique wound-healing product
